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Abstract Receptor activator of NF-UB (RANK) is a recently
cloned member of the tumor necrosis factor receptor (TNFR)
superfamily, and its function has been implicated in osteoclast
differentiation and dendritic cell survival. Many of the TNFR
family receptors recruit various members of the TNF receptor-
associated factor (TRAF) family for transduction of their signals
to NF-UB and c-Jun N-terminal kinase. In this study, the
involvement of TRAF family members and the activation of the
JNK pathway in signal transduction by RANK were investi-
gated. TRAF1, 2, 3, 5, and 6 were found to bind RANK in vitro.
Association of RANK with each of these TRAF proteins was also
detected in vivo. Expression of RANK in cultured cells also
induced the activation of JNK, which was blocked by a
dominant-negative form of JNK. Furthermore, by employing
various C-terminal deletion mutants of RANK, the regions
responsible for TRAF interaction and JNK activation were
identified. TRAF5 was determined to bind to the C-terminal 11
amino acids and the other TRAF members to a region N-
terminal to the TRAF5 binding site. The domain responsible for
JNK activation was localized to the same region where TRAF1,
2, 3, and 6 bound, which suggests that these TRAF molecules
might mediate the RANK-induced JNK activation.
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1. Introduction
Receptor activator of NF-UB (RANK) is a recently cloned
member of the tumor necrosis factor receptor (TNFR) family
[1]. The RANK protein consists of 616 amino acids contain-
ing the cysteine residues conserved in the extracellular domain
of the TNFR family proteins. Its relatively long cytoplasmic
domain (383 amino acids) has little homology with other
TNFR family members. The ligand for RANK, RANKL
[1], was found to be identical to TRANCE (TNF-related ac-
tivation-induced cytokine), ODF (osteoclast di¡erentiation
factor), and OPGL (osteoprotegerin ligand) [2^4]. The expres-
sion level of RANK mRNA is high in thymus, lung, and
trabecular bone and lower in spleen and bone marrow [3],
which suggests physiological functions of RANK in the regu-
lation of bone and immune systems. Consistent with this
suggestion, treatment with RANKL/TRANCE was shown
to enhance the function and survival of T cells and dendritic
cells [1,5]. In addition, RANKL/ODF has been demonstrated
to cause the di¡erentiation of hematopoietic precursor cells
into osteoclasts and to stimulate the bone resorbing activity
of mature osteoclasts [4].
The TNF receptor-associated factor (TRAF) family mole-
cules are cytoplasmic adaptor proteins known to mediate sig-
naling events speci¢cally for members of the TNFR family,
which includes TNFR1, TNFR2, CD30, CD40, CD27, Fas,
4-1BB, Ox40, TR2, and LMP-1 [6,7]. To date six members of
the TRAF family have been identi¢ed. The TRAF2 protein is
recruited to TNFR1 through a death domain-containing mol-
ecule TRADD, whereas all TRAF proteins except TRAF4,
which is localized to the nucleus, have been shown to directly
bind to several TNFR family receptors [8^17]. TRAF family
proteins have a similar structural array consisting of an N-
terminal zinc RING ¢nger, multiple zinc ¢ngers, and C-ter-
minal TRAF-N and TRAF-C domains. The TRAF1 molecule
is unique in that it lacks the RING ¢nger domain [9]. The N-
terminal zinc binding regions of TRAFs serve as e¡ector do-
mains, whereas the TRAF domain appears to be involved in
binding to the cytoplasmic tail of TNFR proteins [12,18,19].
Characterization of binding sites for TRAFs in TNFR family
proteins has led to the identi¢cation of two types of sequence
motif : PXQXT/S [20,21] and EED/EEE [15,20,22]. The
PXQXT/S motif seems to be capable of binding to TRAFs
1, 2, 3, and 5 and the EED/EEE motif binds TRAFs 1, 2, and
3. Characteristic cellular responses to the stimulation of
TNFR family receptors include the activation of the NF-UB
transcription factor and c-Jun N-terminal kinase (JNK) of the
mitogen-activated protein kinase family. The N-terminal zinc
binding motifs of TRAF2, TRAF5, and TRAF6 have been
shown to be responsible for the NF-UB activation induced by
TNFR family proteins [13^15,18,23^25]. Overexpression of
TRAF2, 5, or 6 was reported to activate JNK [26], and
TRAF2 has been implicated in the TNFK-induced activation
of JNK [27]. The role of TRAF2 in the TNFR-induced JNK
activation was further supported by a study with transgenic
mice expressing a dominant-negative TRAF2 [28].
The activation of NF-UB appears to be involved in RANK
signaling as other TNFR family proteins. Ectopic overexpres-
sion of RANK in a cultured cell line and ligation of endog-
enous RANK in T cells pretreated with phytohemagglutinin
and interleukin (IL)-4 resulted in NF-UB activation [1]. In-
volvement of JNK in RANK signaling pathways might also
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be suggested as RANKL/TRANCE stimulation was shown to
cause a modest increase in the JNK activity in T cells [2]. As
TRAF2, 5, and 6 were implicated in the activation of NF-UB
and JNK for some TNFR family members, it may be antici-
pated that some TRAF molecules mediate the RANK-in-
duced responses. In support of this, the amino acid sequence
analysis of the cytoplasmic domain of human RANK reveals
several potential TRAF binding sites: four PXQXT/S-like
motifs (302PDQGG, 353PSQPT, 569PVQEE, and 607PVQEQ)
and three acidic residue triplets (336EED, 346EDE, and
481EEE). To gain insight into the mechanism by which
RANK transmits its signal to the nucleus, the interaction
between RANK and TRAFs and the e¡ect of RANK signal-
ing on JNK activation were characterized in this study.
2. Materials and methods
2.1. Cell culture and transfection
HeLa cells were cultured in DMEM containing 10% FCS and 293-
EBNA cells (Invitrogen) were maintained in DMEM containing 10%
FCS and 250 Wg/ml G418. For transient transfection, 2U105 cells per
well were plated onto 6-well plates. The next day, transfection was
carried out with a mixture of 1^2 Wg DNA and 10 Wl SuperFect
reagent (Qiagen) following the manufacturer’s instructions. 40^48 h
after transfection, cells were harvested. For co-immunoprecipitation
experiments, 1.5U106 cells plated in T-25 £asks were transfected with
4^7 Wg DNA and 20 Wl SuperFect.
2.2. Plasmid constructions
The cDNA encoding the full-length human RANK was obtained
from Human Genome Sciences (Rockville, MD). The T7-tagged
mammalian expression vector of hRANK, pSRa-RANK-T7, was con-
structed by PCR. The sequence of PCR product was veri¢ed by au-
tomated DNA sequencing (Perkin Elmer, ABI 310). RANK C-termi-
nal deletion mutants, pSRa-RANK-605 and -432, were generated
using XhoI (amino acid 605 position) and MscI (amino acid 432
and 513 positions) sites, respectively. A third deletion mutant,
pSRa-RANK-352, was constructed by PCR.
The GST fusion construct of the entire cytoplasmic domain (amino
acids 235^616) of RANK was produced by subcloning PCR ampli¢ed
DNA into pGEX4T-1 (Pharmacia). The cytoplasmic domain deletion
mutants of GST fusion plasmids, pGEX-RANK-ICD-605 and
pGEX-RANK-ICD-432, were constructed by similar approaches as
for pSRa-RANK mutants. GST fusion proteins were puri¢ed as de-
scribed previously [29].
Flag-tagged human TRAF1, 2, 3, and 6 and murine TRAF5 mam-
malian expression vectors, mammalian GST expression vectors
(pEBG) of JNK1 and SEK-K/R, and GST-c-Jun-77 construct were
generously provided by Drs. H.Y. Song (Lilly Co. Center, Indianap-
olis, IN, USA), J.S. Gutkind (NIH, Bethesda, MD, USA) and R.K.
Park (Wonkwang University, Iksan, South Korea), respectively.
2.3. Immunoprecipitation, Western blotting, and in vitro binding assays
Cell lysates were prepared using a lysis bu¡er containing 1% Triton
X-100 and immunoprecipitated with anti-Flag mAb M2 (Eastman
Kodak), immunoprecipitates were resolved by SDS-PAGE, and co-
precipitated proteins were blotted with either anti-T7-HRP or anti-T7
(Novagen) and anti-mouse Ig-HRP (Amersham) as previously de-
scribed [30]. Rabbit anti-GST and anti-RANK sera were produced
using as immunogen GST and GST-RANK cytoplasmic domain pro-
teins, respectively. A small fraction of total cell lysate (1/50^1/100)
was subjected to Western blotting with anti-Flag M2, anti-T7, anti-
RANK or anti-GST.
For in vitro binding experiments, 2^5 Wg of puri¢ed GST-RANK
proteins were incubated with cell lysates from the Flag-TRAF-trans-
fected HeLa or 293-EBNA cells and glutathione beads. Extensively
washed precipitates were separated by SDS-PAGE and subjected to
Western blotting with anti-Flag M2.
2.4. JNK activity assay
For JNK activity assays, 250 Wg of lysates were incubated with
glutathione beads for 2 h at 4‡C, precipitates washed twice in the lysis
bu¡er and twice in the kinase reaction bu¡er, and kinase reaction
performed as previously described [31] with the omission of
[Q-32P]ATP. Samples were resolved by SDS-PAGE and Western
blotted with an antibody speci¢c for phosphorylated c-Jun (New Eng-
land Biolabs, Cat. #9161S). Alternatively, the activity of endogenous
JNK was measured by the solid-phase kinase assay [32] using 3 Wg of
GST-c-Jun-77.
3. Results and discussion
3.1. Interaction of RANK with TRAF family proteins in vitro
Some TNFR family receptors recruit TRAF2, 5, and 6 to
activate NF-UB [23^25], while this activation appears to be
antagonized by TRAF3 binding [17,23,25]. To determine
whether RANK can also utilize TRAF family proteins in
signal transduction, the potential interaction between
RANK and TRAFs was examined by in vitro binding experi-
ments, employing the GST fusion protein of the cytoplasmic
domain of human RANK. When the GST-RANK protein
was incubated with lysates from HeLa or 293-EBNA cells
expressing Flag-tagged TRAF molecules (Fig. 1A) and the
precipitates were subjected to Western blotting with anti-
Flag, TRAF1, 2, 3, 5, and 6 were found to bind RANK
(Fig. 1B). The binding of TRAF to GST-RANK was speci¢c
as the GST control and the GST fusion of protein X, which
does not possess any homology to RANK, showed little bind-
ing, even though comparable amounts of the GST proteins
were used (data not shown). Although the possibility of the
involvement of a third cellular protein mediating the interac-
tions between RANK and TRAFs cannot be excluded, given
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Fig. 1. In vitro binding of TRAF family proteins to RANK. Flag-
tagged human TRAF1, 2, 3, or 6, mouse TRAF5, or control vector
cDNA was transfected into HeLa cells, and a fraction of each cell
lysate was subjected to Western blotting with anti-Flag (A). The cell
lysates were incubated with 2 Wg of either GST, GST fusion protein
of the cytoplasmic domain of RANK (GST-RANK), or that of an
irrelevant protein X (GST-X) and then precipitated using gluta-
thione beads. The precipitates were extensively washed, resolved by
SDS-PAGE, and blotted with anti-Flag (B).
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the high levels of TRAFs expressed in this system, the TRAF
binding to RANK is likely to be direct. Consistent with this,
TRADD, known to mediate TRAF2 association with TNFR1
[8], did not show any binding to GST-RANK (data not
shown). These results indicate that RANK has the potential
to bind multiple TRAF family members and utilize various
TRAF molecules for its signal transduction.
3.2. Interaction of TRAFs and RANK in mammalian cells
To investigate the signal transduction pathways used by
RANK, we expressed the full-length RANK protein as a
T7-tagged form in 293-EBNA cells. When the lysate was
Western blotted with anti-T7 or anti-RANK, the RANK pro-
tein appeared to have the relative molecular mass of about 90
kDa (Fig. 2A, left panel), which was larger than the calculated
size and suggested that RANK may be subject to glycosyla-
tion or other posttranslational modi¢cations. Immunoprecipi-
tation with anti-RANK or anti-T7 also yielded a 90 kDa
immunoreactive protein (Fig. 2A, right panel and data not
shown). Analyses of the expressed RANK protein by non-
denaturing electrophoresis showed a band of approximately
270 kDa (data not shown). Trimerization of TNFR upon
TNF stimulation has been thought to be the mechanism by
which the signal of ligand engagement is transmitted to the
receptor [33,34], and the RANK proteins apparently also
showed the potential to trimerize. To determine whether the
intracellular events in the RANK signal transduction include
the recruitment of TRAF molecule(s), co-immunoprecipita-
tion analyses were performed with cells transfected with the
RANK-T7 and each of the Flag-tagged TRAF molecule
cDNAs. Blotting of the anti-Flag precipitates with anti-T7
showed that TRAF1, 2, 3, 5, and 6 proteins associated with
RANK (Fig. 2B). Results of the reverse analysis, immunopre-
cipitation with anti-T7 and Western blotting with anti-Flag,
were in agreement (data not shown). In some cases, the ex-
pressed RANK protein migrated as a doublet in SDS-PAGE,
and TRAF3 preferentially bound the lower band (Fig. 2B and
data not shown). It is possible that some RANK proteins
existed as a phosphorylated form with retarded mobility
under certain conditions, and TRAF3 binds more e⁄ciently
to the non-phosphorylated form. These co-immunoprecipita-
tion results indicated that RANK can associate with TRAF1,
2, 3, 5, and 6 in vivo, which suggested the involvement of the
multiple TRAF family proteins in the signal transduction by
RANK.
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Fig. 2. Association of the RANK protein with TRAF family mem-
bers in cultured cells. A: T7-tagged RANK cDNA or control vector
plasmid was transfected into 293-EBNA cells and a fraction of cell
lysate was analysed for RANK expression by Western blotting with
either monoclonal anti-T7 or polyclonal anti-RANK (left panel).
The lysates were also immunoprecipitated with anti-RANK and the
precipitates were blotted with anti-T7 (right panel). B: 293-EBNA
cells were transfected with RANK-T7 and each of the TRAF plas-
mids, cell lysates were immunoprecipitated with anti-Flag, and the
precipitates were subjected to Western blotting with anti-T7 (top
panel). A fraction of each cell lysate was analysed by blotting with
anti-Flag to verify the expression of all TRAF proteins (bottom
panel).
Fig. 3. Activation of JNK induced by RANK expression. A: 293-
EBNA cells were transfected with RANK-T7 and a mammalian
GST expression construct of JNK1, and the JNK activity was meas-
ured using equal amounts of cell lysates as described in Section 2
(left top panel). Expression of RANK and JNK was con¢rmed by
Western blotting with anti-T7 and anti-GST, respectively, of ali-
quots of cell lysates (left middle and bottom panels). Alternatively,
cells were transfected with RANK-T7 and the activity of endoge-
nous JNK was measured by solid-phase kinase assays as described
in Section 2 (right top panel). Expression of RANK was analyzed
by anti-T7 blotting of aliquots of these lysates (right bottom panel).
B: Cells were transfected with indicated plasmids. JNK activity was
determined by solid-phase kinase assays (top panel), and the expres-
sion of RANK and SEK-K/R was veri¢ed by Western blotting of
the lysates with anti-RANK (middle panel) and anti-GST (bottom
panel), respectively.
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3.3. RANK signaling to JNK
TRAF2 and TRAF6 have been shown to mediate the acti-
vation of JNK by TNFR1 and IL-1R, respectively [27,35].
Transient overexpression of TRAF2, 5, and 6 has also been
found to induce the activation of this kinase [26]. To deter-
mine whether JNK activation is involved in RANK signal
transduction pathways, RANK and GST-JNK1 were trans-
fected into 293-EBNA cells and the activity of JNK was meas-
ured after precipitation with glutathione beads. The transfec-
tion of RANK led to the elevated activity of the ectopically
expressed kinase compared to the vector transfected control
(Fig. 3A, left panel). This increase in JNK activity was not
due to di¡erential levels of expression of the kinase as proven
by an anti-GST blot (Fig. 3A, left bottom panel). The
RANK-induced JNK activation was also observed with the
kinase endogenously present when the cells were transfected
with RANK cDNA alone and the solid-phase kinase assay
was performed (Fig. 3A, right panel). Furthermore, this acti-
vation was blocked by the coexpression of SEK-K/R, a kin-
ase-inactive form of SEK/JNKK which is an upstream acti-
vating kinase of JNK (Fig. 3B). These results imply that the
signaling pathways utilized by RANK include one leading to
JNK activation, and that the conventional JNK activation
cascade involving SEK may lie in the pathway transducing
RANK signals to the nucleus.
3.4. E¡ects of C-terminal deletions on TRAF binding to and
JNK activation by RANK
To locate the regions in the cytoplasmic tail of RANK
responsible for TRAF binding and JNK activation, the C-
terminal deletion mutants RANK-605, RANK-432, and
RANK-352 were generated as mammalian expression plas-
mids and GST fusion proteins of the intracellular domain
segments of the RANK variants (GST-RANK-ICD-605 and
GST-RANK-ICD-432) were produced (Fig. 4A). When the
various GST-RANK fusion proteins were incubated with ly-
sates from 293-EBNA cells expressing Flag-tagged TRAF
molecules, GST-RANK-ICD-605 showed binding to
TRAF1, 2, 3 and 6 but not to TRAF5, whereas binding of
all tested TRAFs was observed with the wild type RANK
fusion protein (Fig. 4B). The GST-RANK-ICD-432 failed to
bind to any of the TRAF molecules (Fig. 4B). The lack of
TRAF binding to GST-RANK-ICD-432 was not due to an
insu⁄cient amount of this fusion protein as comparable
amounts of the wild type and mutant RANK fusion proteins
were used (data not shown). These results indicate that the
binding site for TRAF5 is located in the C-terminal 11 amino
acids of RANK, and that for TRAF1, 2, 3, and 6 it lies in
amino acids 433^605. Next, using the wild type and mutant
RANK constructs encoding the extracellular and transmem-
brane domains as well as the cytoplasmic domain, identi¢ca-
tion of the region responsible for the activation of JNK was
pursued. The deletion mutant RANK-605 could induce JNK
activation to an extent comparable to that caused by the wild
type RANK protein (Fig. 4C). In contrast, the deletion mu-
tants RANK-432 and -352 could not elevate the JNK activity
above the basal level (Fig. 4C). These results map the JNK
activation domain to amino acids 433^605 in the cytoplasmic
tail of RANK which was also required for the binding of
TRAF1, 2, 3, and 6.
In this study, we investigated the signal transduction path-
ways of RANK. The RANK protein was found to bind
TRAF1, 2, 3, 5, and 6 in vitro (Fig. 1B) and to be associated
with these TRAF molecules in vivo (Fig. 2B). In experiments
with C-terminal deletion mutants of RANK, the binding site
for TRAF5 was determined to be the C-terminal end (amino
acids 606^616), and that for the other TRAFs amino acids
433^605 (Fig. 4B). The TRAF5 binding region of RANK
contains the sequence 607PVQEQ similar to the PXQXT motif
shown to be important for the interaction of CD40, CD30, or
LMP-1 with TRAF1, 2, 3, and 5 [15,17,20,21]. Similar sequen-
ces, PIQEE and PIQED, have been implicated in the binding
of TRAF1, 2, and 3 to CD27 and Ox40, respectively [36,37],
which indicates the minimal sequence requirement for TRAF
binding might be proline and glutamine with an intervening
amino acid. Another PXQX motif (569PVQEE) is present in
the C-terminal portion of RANK where TRAF1, 2, 3, and 6
were found to bind. In addition, there is an acidic triplet
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Fig. 4. Identi¢cation of the regions in the RANK cytoplasmic do-
main responsible for binding of TRAFs and JNK activation. A:
The schematic structure of the cytoplasmic domain of hRANK is
shown. P1, P2, P3, and P4 denote the PXQX motifs, and A1, A2,
and A3 indicate the acidic triplet motifs present in RANK. The in-
tracellular domains of the wild type and C-terminal deletion mu-
tants (RANK-ICD-WT, -605, and -432) were produced as GST fu-
sion proteins. In addition, mammalian expression plasmids (pSRa)
containing the extracellular and transmembrane domains as well as
the cytoplasmic tail were generated for the wild type RANK and
RANK-605, -432, and -352 deletion mutants. B: The GST fusion
proteins of the wild type and deletion mutants of RANK intracellu-
lar domain were incubated with lysates from 293-EBNA cells ex-
pressing Flag-tagged TRAF proteins. The complexes were precipi-
tated with glutathione beads and subjected to Western blotting with
anti-Flag. C: 293-EBNA cells were transfected with the indicated
pSRa-RANK construct or the control vector. The JNK activity was
measured with equal amounts of cell lysates by the solid-phase kin-
ase assay as described in Section 2.
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sequence 481EEE which was shown to mediate the binding of
TRAF1, 2, and 3 to CD30 and 4-1BB [20,22]. Whether the
569PVQEE and/or 481EEE sequences are critical for the inter-
action between RANK and TRAF1, 2, 3, or 6 is under inves-
tigation by introduction of point mutations in those sequen-
ces.
The JNK activation cascade was found to be involved in
RANK signal transduction (Fig. 3). The region responsible
for the stimulation of JNK activity was mapped to amino
acids 433^605 of RANK (Fig. 4C), where also the association
of TRAFs 1, 2, 3, and 6, but not that of TRAF5, apparently
occurred (Fig. 4B), excluding the role of TRAF5 in this aspect
of RANK signaling. Considering that TRAF2, 5, and 6 have
been reported to be involved in the JNK activation induced
by some TNFR superfamily receptors [9,13,23,25,27,28,38],
the RANK-dependent JNK activation might be expected to
be mediated by TRAF2 and/or TRAF6. Recently, TRAF3
was reported to participate in the CD40-induced JNK activa-
tion [39], implying that the mediation of JNK activation by
TRAF3 is possible in RANK signal transduction. In addition,
the possibility that other TRAF molecules yet to be identi¢ed
bind to the same region of RANK and link RANK to the
JNK cascade or that the RANK-induced JNK activation is
TRAF-independent cannot be ruled out.
During the preparation of this article, studies on TRAF
binding to human and mouse RANK were reported [40,41].
In those studies, TRAF2, 5, and 6 were found to bind
hRANK and additional TRAF1 and 3 to bind mRANK in
vitro. The in vivo association was demonstrated only with
TRAF2 and hRANK. Here, we showed the in vivo interac-
tion of hRANK with TRAF1, 3, 5, and 6, in addition to
TRAF2. The binding sites for TRAFs and the role of
TRAF binding in the signal transduction appeared di¡erent
for human and mouse RANK proteins. The binding site for
TRAF6 in hRANK was mapped to the C-terminal 85 amino
acids [40], whereas that for mRANK seems to be N-terminal
to that region [41]. In our study, TRAF5 was found to bind
the very C-terminal 11 amino acids that contain the PXQX
motif (PVQEQ at 607^611 of hRANK, corresponding to ami-
no acids 604^608 of mRANK). However, in mRANK,
TRAF5 binding appeared to occur in a more upstream por-
tion [41]. In this regard, it is intriguing to note that mRANK
contains an additional PXQX motif (595PRQKD) in the
TRAF5 binding region. Additionally, the domain responsible
for NF-UB activation signaling was identi¢ed as the C-ter-
minal 85 amino acids in hRANK [40], which was least e¡ec-
tive among multiple regions that induced NF-UB activation
for mRANK [41]. Further investigations on RANK signal
transduction and comparative studies on physiological func-
tions of the RANK protein in mice and humans will be re-
quired to resolve these discrepancies and to understand the
structure-function relationships of this new TNFR family re-
ceptor.
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